This program will emphasize the evidence-based strategy for the current treatment and leading-edge research in novel therapeutics, as well as advances in medical and surgical approaches to a variety of neurological disorders.
Kansas City, MO (PRWEB) July 23, 2015
Saint Luke’s Marion Bloch Neuroscience Institute, one of the region’s premier neuroscience facilities, in conjunction with the Institute for International Medicine (INMED) and Saint Luke’s Hospital of Kansas City will present its 3rd Annual Advances in Neuroscience Symposium on Friday, Sept. 25, 2015 at the InterContinental Kansas City at the Plaza.
The program will focus on diagnosis and treatment of a broad range of neurologic disorders, featuring presentations by Saint Luke’s invited faculty members. Special guest presenters include internationally renowned neuroscientists, including Joseph C. Masdeu, M.D., who will present on advances in dementia imaging, and C. Warren Olanow, M.D. who will speak about future directions in the treatment of Parkinson’s disease.
“Saint Luke’s is committed to providing the best evidence-based treatment for our patients. In recent years there have been significant advances in the diagnosis and treatment of many neurological diseases,” said Stanley P. Fisher, M.D., co-director of the Neuroscience Institute. “This program will emphasize the evidence-based strategy for the current treatment and cutting-edge research in novel therapeutics, as well as advances in medical and surgical approaches to a variety of neurological disorders.”
Presenters will present on a variety of topics, including sessions on:
- new medical and surgical therapies for the treatment of patients with drug-resistant epilepsy
- novel ideas in dementia imaging and its role in current and future clinical trials
- new and emerging therapies for the treatment of multiple sclerosis
- new and future therapies for motor and non-motor symptoms of Parkinson’s disease
- new imaging, medical, and surgical techniques for the evaluation and treatment of chronic back pain and primary brain tumors
- understanding the nature of concussion, risk associated with repeated concussions, and best practice approaches to athletes with concussions
The conference has been planned and implemented in accordance with the Essential Areas and Policies of the Missouri State Medical Association through the joint providership of INMED and Saint Luke’s Hospital of Kansas City. Continuing education credits will be offered to physicians, physician assistants, advanced nurse practitioners and other healthcare professionals with an interest in neurology who attend the event. For more information and to register visit saintlukeskc.org/symposium.
About Saint Luke’s Marion Bloch Neuroscience Institute
Saint Luke’s Marion Bloch Neuroscience Institute (SLMBNI) is a comprehensive center for neuroscience research, education, and evidence-based medicine, that combines faculty in neurology, neurosurgery, interventional neuroradiology, neurotology, psychiatry, and physical medicine and rehabilitation. Together SLMBNI faculty provide patient-centered leading-edge care to thousands of patients from all over the country each year. As a member of Saint Luke’s Health System, SLMBNI is a global leader in utilizing both drug and mechanical interventions to reverse the permanent and debilitating effects of ischemic stroke. Its legacy of innovation began in 1993 when doctors performed one of the world’s first intra-arterial stroke reversal procedures. Since then, Saint Luke’s specialists have continued to pioneer new stroke treatments and reverse strokes in thousands of patients through its network of stroke centers. Located in Kansas City, MO, SLMBNI brings together a team of highly specialized neuroscientists to provide comprehensive treatment for the most complex neurological diseases, including stroke, epilepsy, brain tumors, Parkinson’s and Alzheimer’s diseases, multiple sclerosis, headaches and facial pain, as well as aneurysms and intracerebral hemorrhages. The Institute’s multispecialty team provides the latest in minimally invasive spinal surgical techniques for the treatment of acute and chronic back pain. SLMBNI strives to be a national leader in neurological treatment and care by advancing clinical research and evidence-based clinical practice.
Saint Luke’s Health System
Saint Luke’s Health System consists of 10 area hospitals and several primary and specialty care practices, and provides a range of inpatient, outpatient, and home care services. Founded as a faith-based, not-for-profit organization, our mission includes a commitment to the highest levels of excellence in health care and the advancement of medical research and education. The health system is an aligned organization in which the physicians and hospitals assume responsibility for enhancing the physical, mental, and spiritual health of people in the Kansas City metropolitan area and the surrounding region.